World Health Organisation (WHO) and COVAX partners on Sunday applauded G7 nations’ commitment to sharing 870 million doses of COVID-19 vaccines to assist end the acute phase of the pandemic.
WHO, in a statement, commended G7 countries for the commitment to delivering half of the 870 million doses by end of 2021.
G7 countries are a group of the world’s seven largest advanced economies namely: United Kingdom, Germany, Italy, Canada, France, Japan and United States
“G7 reaffirmed their support for COVAX as the primary route for providing vaccines to the poorest countries,’’ it stated.
In a landmark agreement at the just concluded G7 summit at Cornwall, UK, the leaders had pledged to share COVID-19 vaccine doses internationally, in support of global equitable access and to help end the acute phase of the pandemic.
The G7 has committed one billion doses since February virtual G7 Early Leaders’ Summit, including pledges made at the G20 Global Health Summit.
According to the statement, COVAX partners welcome this commitment, along with continued support for exporting in significant proportions, promotion of voluntary licensing and not-for-profit global production.
“COVAX welcomes doses sharing commitments for 870 million doses to support equitable access to vaccines in 2021 and 2022, with the aim to deliver at least half by the end of 2021,’’ it said.
COVAX, set up by WHO, GAVI the vaccine alliance and the Coalition for Epidemic Preparedness Innovations (CEPI) are part of the Access to COVID-19 Tools (ACT) accelerator to equitably provide COVID-19 diagnostics, treatments and vaccines to all people globally, regardless of their wealth.
in addition, it stated that COVAX looked forward to seeing doses flowing to countries as soon as possible.
Police recover N1.3m from suspected kidnappers
“Facing an urgent supply gap, COVAX is focused on securing as many shared doses as possible immediately, as the third quarter of this year is when the gap between deliveries and countries’ ability to absorb doses will be greatest.
“COVAX will work with the G7 and other countries that have stepped up to share doses as rapidly and equitably as possible.
“This will help address short-term supply constraints currently impacting the global response to COVID-19 and minimise the prospect of future deadly variants.
“COVAX also urges multilateral development banks to urgently release funding to help countries prepare their health systems for large-scale rollout of vaccines in the coming months,” it stated.
Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance also said, “this is an important moment of global solidarity and a critical milestone in the push to ensure those most at risk, everywhere are protected.”.
